Diagnostics Growth OralDNA Labs operates in a niche of specialty diagnostics for oral medicine and has a track record of developing reliable, cost effective tests. This suggests upside in expanding partnerships with dental practices, clinics, and hospitals needing advanced oral disease detection and prognostics.

Salivary Testing Momentum Historical launches of OraRisk salivary diagnostics including PCR tests for SARS-CoV-2 indicate capability and agility in leveraging saliva-based tests. This positions the company to pursue growth in saliva testing panels that integrate with dental and medical workflows.

Regulatory Experience Having secured Emergency Use Authorization for a coronavirus test showcases regulatory credibility and a potential differentiator when engaging with hospital systems and providers seeking compliant, rapid diagnostics solutions.

Health Tech Stack Reliance on cloud and digital tools (AWS, Google Workspace, SendGrid, WordPress) and web services to support tests, documentation, and outreach suggests opportunities to integrate with EHR/practice management systems and digital marketing channels to streamline adoption.

Mid-Market Opportunity With a small to mid-sized employee base and revenue in the low tens of millions, there is likely appetite for scaled partnerships, distribution arrangements, and joint marketing with mid-market dental groups, specialty clinics, and regional hospital networks seeking advanced diagnostics without enterprise-scale pricing.